Organization: Health Canada
Year: 2022
Month: October
Request Number: A-2022-000549
Request Summary: Adverse Drug Reaction (ADR) for C1 ESTERASE INHIBITOR (HUMAN). Report number: E2B_05347402. ADR for CUVITRU. Report number: 000992706. ADRs for GAMMAGARD LIQUID. Report numbers: 000990508, 000992976, 000990937. ADRs for IMMUNOGLOBULIN (HUMAN). Report numbers: E2B_05338399, E2B_05336219, E2B_05338367, E2B_05326615, E2B_05314607.
Disposition: Disclosed in part
Number of pages: 163